Lifeward (NASDAQ:LFWD) Trading Up 3.9% – Still a Buy?

Lifeward Ltd. (NASDAQ:LFWD) shares rose 3.9% during mid-day trading on Friday . The company traded as high as $7.20 and last traded at $7.20. 4,696 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 6,474 shares. The stock had previously closed at $6.93.

Analyst Upgrades and Downgrades

LFWD has been the subject of several recent research reports. HC Wainwright boosted their target price on shares of Lifeward to $10.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research report on Tuesday, April 21st. Finally, Zacks Research cut shares of Lifeward from a “hold” rating to a “strong sell” rating in a research note on Wednesday, June 3rd. One equities research analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $10.00.

Lifeward Stock Up 3.9%

The company has a quick ratio of 1.82, a current ratio of 2.40 and a debt-to-equity ratio of 1.16. The company has a fifty day simple moving average of $7.04 and a 200-day simple moving average of $7.06. The firm has a market cap of $20.23 million, a P/E ratio of -0.37 and a beta of 0.36.

Lifeward (NASDAQ:LFWD) last posted its quarterly earnings data on Friday, May 15th. The company reported ($6.70) EPS for the quarter, missing the consensus estimate of ($1.18) by ($5.52). Lifeward had a negative return on equity of 243.14% and a negative net margin of 123.66%.The company had revenue of $3.92 million during the quarter, compared to the consensus estimate of $5.78 million. On average, equities analysts anticipate that Lifeward Ltd. will post -4.27 earnings per share for the current year.

Institutional Investors Weigh In On Lifeward

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LFWD. HRT Financial LP raised its stake in Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the period. Virtu Financial LLC boosted its position in shares of Lifeward by 158.0% in the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after purchasing an additional 37,037 shares during the period. Jane Street Group LLC boosted its position in shares of Lifeward by 77.3% in the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after purchasing an additional 29,927 shares during the period. Finally, Citadel Advisors LLC increased its stake in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares in the last quarter. Institutional investors own 26.76% of the company’s stock.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.